Path_lab

. S60 - NODA SECTOR 34 CC SHOP NO. 1, C-74, JASMINE MARKET, OPP.K ANGAROO KIDS SCHOOL, SECTOR 34, NOIDA Name : Mr. MURGA NANDAN Collected : 11/10/2015 11:13:00AM Received : 11/10/2015 11:13:54AM Lab No. : 123318487 Age: 36 Years Gender: Male Reported : 12/10/2015 10:48:40AM A/c Status : P Ref By : SELF Report Status : Final Test Name Results Units Bio. Ref. Interval DIABETES PANEL 2 105.00 mg/dL 70.00 - 100.00 213.00 mg/dL 70.00 - 140.00 Glucose, Fasting 193.00 mg/dL <200.00 Glucose, PP 281.00 mg/dL <150.00 Cholesterol, Total 39.00 mg/dL 40.00 - 60.00 Triglycerides 97.80 mg/dL <100.00 HDL Cholesterol 10.90 mg/dL 3.50 - 7.20 LDL Cholesterol, Calculated 0.87 mg/dL 0.67 - 1.17 Uric Acid 6.90 % Creatinine, Serum Pale yellow HbA1c # Slight Lemon Yellow 1.001 - 1.030 URINE EXAMINATION, ROUTINE; URINE, R/E 1.020 5.0 - 8.0 Colour 5 Nil Specific Gravity Nil Nil pH Nil Nil Proteins Nil Nil Glucose Nil Normal Ketones Normal Negative Bilirubin Negative Negative Urobilinogen Negative Negative Leucocyte Esterase Negative 0-5 WBC / hpf Nitrite Negative Few R.B.C. Few Nil /lpf Pus Cells Nil Nil Epithelial Cells Nil - Casts Nil Crystals 24.00 - 392.00 Others <5.00 mg/L <30.00 Microalbumin Urine @ 130.86 mg/dL Microalbumin <30 mg/g creatinine Creatinine Microalbumin : Creatinine Ratio PatientReportSCSuperPanel.GENERAL_BOX_SC (Version: 4) Page 1 of 3 # Not in NABL scope

. S60 - NODA SECTOR 34 CC SHOP NO. 1, C-74, JASMINE MARKET, OPP.K ANGAROO KIDS SCHOOL, SECTOR 34, NOIDA Name : Mr. MURGA NANDAN Collected : 11/10/2015 11:13:00AM Received : 11/10/2015 11:13:54AM Lab No. : 123318487 Age: 36 Years Gender: Male Reported : 12/10/2015 10:48:40AM A/c Status : P Ref By : SELF Report Status : Final Test Name Results Units Bio. Ref. Interval Interpretation ------------------------------------------------------------------ | NCEP RECOMMENDATIONS| CHOLESTEROL| TRIGLYCERIDES| LDL CHOLESTEROL| | FOR >12 YEARS | in mg/dL | in mg/dL | in mg/dL | |---------------------|------------|--------------|----------------| | Optimal | <200 | <150 | <100 | |---------------------|------------|--------------|----------------| | Near/Above Optimal | - |- | 100-129 | |---------------------|------------|--------------|----------------| | Borderline High | 200-239 | 150-199 | 130-159 | |---------------------|------------|--------------|----------------| | High | >=240 | 200-499 | 160-189 | |---------------------|------------|--------------|----------------| | Very High |- | >=500 | >=190 | ------------------------------------------------------------------ ------------------------------------------------------------------------------- | | As per American Diabetes Association (ADA) |-------------------------------------------------------------------------------| | Reference Group | HbA1c in % | |-------------------------------|-----------------------------------------------| | Non diabetic adults >=18 years| 4.0 - 6.0 | |-------------------------------|-----------------------------------------------| | At risk | >=6.0 to <= 6.5 | |-------------------------------|-----------------------------------------------| | Diagnosing Diabetes | > 6.5 | |-------------------------------|-----------------------------------------------| | Therapeutic goals for glycemic| Adults | | control | . Goal of therapy: < 7.0 | | | . Action suggested: > 8.0 | | | Pediatric patients | | | . Toddlers & Preschoolers: > 7.5 to < 8.5 | | | . 6 - 12 years : < 8.0 | | | . 13 - 19 years : < 7.5 | ------------------------------------------------------------------------------- Note: 1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may still have a high concentration of HbA1c. Converse is true for a diabetic previously under good control but now poorly controlled . 2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life expectancy and no significant cardiovascular disease. In patients with significant complications of diabetes, limited life expectancy or extensive co-morbid conditions, targeting a goal of < 7.0 % may not be appropriate. Comments HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better indicator of long term glycemic control as compared to blood and urinary glucose determinations. ADA criteria for correlation between HbA1c & Mean plasma glucose levels PatientReportSCSuperPanel.GENERAL_BOX_SC (Version: 4) # Not in NABL scope Page 2 of 3

. S60 - NODA SECTOR 34 CC SHOP NO. 1, C-74, JASMINE MARKET, OPP.K ANGAROO KIDS SCHOOL, SECTOR 34, NOIDA Name : Mr. MURGA NANDAN Collected : 11/10/2015 11:13:00AM Received : 11/10/2015 11:13:54AM Lab No. : 123318487 Age: 36 Years Gender: Male Reported : 12/10/2015 10:48:40AM A/c Status : P Ref By : SELF Report Status : Final Test Name Results Units Bio. Ref. Interval --------------------------------------- | HbA1c(%) | Mean Plasma Glucose (mg/dL)| |----------|----------------------------| | 6 | 126 | |----------|----------------------------| | 7 | 154 | |----------|----------------------------| | 8 | 183 | |----------|----------------------------| | 9 | 212 | |----------|----------------------------| | 10 | 240 | |----------|----------------------------| | 11 | 269 | |----------|----------------------------| | 12 | 298 | --------------------------------------- Dr. Nimmi Kansal Dr. Preet Kaur MD (Biochemistry) MBBS, MD (PATH) HOD Biochem & IA Chief of Lab -------------------------------End of report -------------------------------- PatientReportSCSuperPanel.GENERAL_BOX_SC (Version: 4) Page 3 of 3 # Not in NABL scope